Brief: Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain

Zoetis

04/02/2025 14:20

Feb 4 (Reuters) - Zoetis Inc  ZTS.N :
    * ZOETIS ANNOUNCES U.S. LABEL UPDATE FOR LIBRELA®
(BEDINVETMAB
INJECTION), A TREATMENT TO CONTROL CANINE OSTEOARTHRITIS (OA)
PAIN
    * ZOETIS INC: PLANS TO IMMEDIATELY IMPLEMENT UPDATED LABEL
BASED
ON U.S. POST-APPROVAL EXPERIENCE WITH LIBRELA
    * ZOETIS INC: REMAINS CONFIDENT IN SAFETY AND EFFECTIVENESS
OF
LIBRELA

Source text:  ID:nBwbY47lqa 
Further company coverage:  ZTS.N 

 ((Reuters.Briefs@thomsonreuters.com;))